DEFA14A: Tharimmune Inc. Corrects Proxy Statement Regarding Beneficial Ownership
Proxy Statement Supplement
Tharimmune Inc. issues a supplement to its proxy statement to correct an error related to the reported beneficial ownership of shares by Vincent LoPriore.
Summary
- Tharimmune Inc. has filed a supplement to its definitive proxy statement dated April 30, 2025.
- The supplement, dated May 2, 2025, addresses an error in the Security Ownership table within the original proxy statement.
- The error involved the omission of certain shares beneficially owned by Vincent LoPriore, which are indirectly held through an entity he controls.
- The corrected table reflects LoPriore's total beneficial ownership as of the record date, April 28, 2025.
- The corrected table replaces the original table in the Proxy Statement.
- The total number of outstanding shares of common stock as of the Record Date is 2,209,910.
- As a group, all named executive officers and directors beneficially own 326,058 shares, representing 14.31% of the company's common stock.
Sentiment
Score: 7
Explanation: The document is a neutral correction of information, indicating attention to detail and compliance. It doesn't inherently suggest positive or negative sentiment, but accuracy is generally viewed favorably.
Positives
- The company is transparently correcting an error in its proxy statement.
- The supplement provides stockholders with accurate information regarding beneficial ownership.
Industry Context
Proxy statements and their supplements are standard documents for publicly traded companies, ensuring transparency and compliance with SEC regulations regarding shareholder meetings and corporate governance.
Stakeholder Impact
- Shareholders receive corrected information regarding beneficial ownership, ensuring transparency and informed voting decisions.
Next Steps
- Stockholders should review the supplement in conjunction with the original proxy statement before voting.
- Stockholders will vote on proposals at the Annual Meeting on June 10, 2025.
Key Dates
| Date | Description |
|---|---|
| April 28, 2025 | Record date for determining stockholders eligible to vote at the Annual Meeting |
| April 30, 2025 | Date of the original definitive proxy statement |
| May 2, 2025 | Date of the proxy statement supplement |
| June 10, 2025 | Date of the Annual Meeting of Stockholders |
Keywords
proxy statement, beneficial ownership, Tharimmune, shares, stockholders, Vincent LoPriore
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.